Atara Biotherapeutics (ATRA) Other Non-Current Assets (2013 - 2026)

Atara Biotherapeutics has reported Other Non-Current Assets for 14 years, with the latest figure at $890000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 68.71% year-over-year to $890000.0; the trailing twelve-month figure through Mar 2026 stood at $890000.0 (down 68.71% YoY), and the FY2025 full-year result was $886000.0, down 71.45% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $890000.0, roughly flat from $886000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $51.4 million in Q1 2022, with the low at $881000.0 in Q3 2025.
• Historically, Other Non-Current Assets has averaged $6.9 million across 5 years, with a median of $3.7 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 6954.73% — and 2023, when it slumped 86.57%.
• Atara Biotherapeutics' Other Non-Current Assets stood at $7.0 million in 2022, then plunged by 30.98% to $4.8 million in 2023, then slumped by 35.94% to $3.1 million in 2024, then sank by 71.45% to $886000.0 in 2025, then gained by 0.45% to $890000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $890000.0 (Q1 2026), $886000.0 (Q4 2025), and $881000.0 (Q3 2025), per Business Quant data.